Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+14.3%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$127M
Cap. Flow %
-0.79%
Top 10 Hldgs %
35.05%
Holding
1,426
New
92
Increased
658
Reduced
348
Closed
103

Sector Composition

1 Real Estate 52.11%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.83%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OLMA icon
1226
Olema Pharmaceuticals
OLMA
$570M
$3K ﹤0.01%
+224
New +$3K
RAPT icon
1227
RAPT Therapeutics
RAPT
$214M
$3K ﹤0.01%
13
RGNX icon
1228
Regenxbio
RGNX
$490M
$3K ﹤0.01%
146
SANA icon
1229
Sana Biotechnology
SANA
$752M
$3K ﹤0.01%
767
SLRN
1230
DELISTED
ACELYRIN
SLRN
$3K ﹤0.01%
+398
New +$3K
SVRA icon
1231
Savara
SVRA
$643M
$3K ﹤0.01%
+553
New +$3K
VERA icon
1232
Vera Therapeutics
VERA
$1.54B
$3K ﹤0.01%
+182
New +$3K
ZNTL icon
1233
Zentalis Pharmaceuticals
ZNTL
$126M
$3K ﹤0.01%
212
ZYME icon
1234
Zymeworks
ZYME
$1.14B
$3K ﹤0.01%
+286
New +$3K
RVNC
1235
DELISTED
Revance Therapeutics, Inc.
RVNC
$3K ﹤0.01%
331
ICVX
1236
DELISTED
Icosavax, Inc. Common Stock
ICVX
$3K ﹤0.01%
+205
New +$3K
CNTA
1237
Centessa Pharmaceuticals
CNTA
$2.11B
$2K ﹤0.01%
211
COGT icon
1238
Cogent Biosciences
COGT
$1.82B
$2K ﹤0.01%
281
CSTL icon
1239
Castle Biosciences
CSTL
$683M
$2K ﹤0.01%
86
EOLS icon
1240
Evolus
EOLS
$495M
$2K ﹤0.01%
162
ETNB icon
1241
89bio
ETNB
$1.32B
$2K ﹤0.01%
187
GLPG icon
1242
Galapagos
GLPG
$2.2B
$2K ﹤0.01%
51
KNSA icon
1243
Kiniksa Pharmaceuticals
KNSA
$2.65B
$2K ﹤0.01%
139
LYEL icon
1244
Lyell Immunopharma
LYEL
$233M
$2K ﹤0.01%
46
MGNX icon
1245
MacroGenics
MGNX
$126M
$2K ﹤0.01%
209
NRIX icon
1246
Nurix Therapeutics
NRIX
$758M
$2K ﹤0.01%
152
PHAT icon
1247
Phathom Pharmaceuticals
PHAT
$875M
$2K ﹤0.01%
167
REPL icon
1248
Replimune Group
REPL
$494M
$2K ﹤0.01%
200
SIGA icon
1249
SIGA Technologies
SIGA
$603M
$2K ﹤0.01%
270
SPRY icon
1250
ARS Pharmaceuticals
SPRY
$995M
$2K ﹤0.01%
367